Fig. 1From: Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspectiveStudy design. ANSE, annual nutritional status evaluation; CGMP-AA, casein glycomacropeptide supplements; HPA, hyperphenylalaninaemia; L-AA, phenylalanine-free L-amino acid supplements; PKU, phenylketonuriaBack to article page